| Name | Shares allotted | % of global offering | % of post-IPO shares | Lock-up |
|---|---|---|---|---|
| Cordial Solar Limited | 0 | 3.13% | — | 6 months |
| GIC Private Limited | 0 | 21.00% | — | 6 months |
| Hillhouse Funds | 0 | 3.13% | — | 6 months |
| Invesco Advisers, Inc | 0 | 5.88% | — | 6 months |
| Millennium Capital Management (Singapore) Pte. Ltd. | 0 | 2.35% | — | 6 months |
| Oaktree Funds | 0 | 1.57% | — | 6 months |
| UBS Asset Management (Singapore) Ltd. | 0 | 4.70% | — | 6 months |
The IPO was heavily oversubscribed at 454.85x, reflecting intense market demand. Despite this, the hit rate of 45.34% indicates a relatively high allocation rate, likely due to a large applicant pool of 203,874 individuals. The offer price was set at HK$44.05, though no range data is available for comparison. This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.
The expected allocation sharply differs between tiers: investors in the last A-tier (甲尾) receive only 0.5751 lots on average, while the first B-tier (乙头) secures exactly 1.0 lot, a 74% advantage. This wide gap suggests that applying at the B-head threshold was significantly more efficient in obtaining a full lot allocation, even after accounting for the higher capital requirement. Broker fee structures and actual costs may vary, and this analysis does not constitute investment advice. This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.
Mainland Chinese investors dominated participation at 71.2%, typical for popular Hong Kong IPOs. The applicant base skews male (61.9%) and has an average age of 41.2, indicating a mature, likely experienced investor profile. Regional breakdowns beyond mainland vs. Hong Kong were not provided, but high mainland interest often correlates with strong sentiment. Data may contain errors or omissions from source documents — verify against official HKEX filings. This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.
This page shows allotment analysis for Hengrui Pharma (01276): one-lot hit rate, Pool A/B allotment distribution, oversubscription multiple, and grey-market and first-day performance. Data is parsed from the HKEX allotment results announcement. How allotment rates and clawback work is explained in How Hong Kong IPO Allotment Rates Work.

